Relacorilant: all 25 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerNot yet recruitingNCT07763496Phase 2
- Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaRecruitingNCT07259317Phase 2
- A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate CancerRecruitingNCT05726292Phase 2
- Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube CancerActive, not recruitingNCT05257408Phase 3Results posted
- Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal AdenocarcinomaTerminatedNCT04329949Phase 3Results posted
- A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal AdenomasCompletedNCT04308590Phase 3Results posted
- Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT03776812Phase 2Results posted
- A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing SyndromeCompletedNCT03697109Phase 3Results posted
- Study to Evaluate CORT125134 in Participants With Cushing's SyndromeCompletedNCT02804750Phase 2Results posted
- Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid TumorsCompletedNCT02762981Phase 1/2Results posted
- A Study to Evaluate the Pharmacokinetics of the Current Capsule Formulation of CORT125134 in Healthy SubjectsCompletedNCT06094790Phase 1
- A Study to Evaluate the Effect of Food on the Oral Bioavailability of Relacorilant in Healthy SubjectsCompletedNCT06094738Phase 1
- A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of RelacorilantCompletedNCT06094725Phase 1
- A Study to Evaluate the Pharmacokinetics of the CORT125134 Phase 2 Formulation in Healthy Male SubjectsCompletedNCT06094712Phase 1
- Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy ParticipantsCompletedNCT05347979Phase 1
- T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy VolunteersCompletedNCT04795479Phase 1
- Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)CompletedNCT04373265Phase 1
- Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate CancerCompletedNCT03674814Phase 1
- Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeActive, not recruitingNCT03604198Phase 2
- A Study to Determine the Relative Bioavailability of Two New Relacorilant Capsule VariantsCompletedNCT03540836Phase 1
- Study in Healthy Subjects to Determine the Effect of an Inhibitor on Exposure to Relacorilant and Its MetabolitesCompletedNCT03512548Phase 1
- CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)CompletedNCT03508635Phase 1
- Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450sCompletedNCT03457597Phase 1
- Relacorilant Food Effect Study in Healthy SubjectsCompletedNCT03442621Phase 1
- A Study Designed to See How [14C]-CORT125134 is Taken up, Broken Down and Removed From the BodyCompletedNCT03067376Phase 1